Sphincter-Saving Rectal Cancer Surgery by Dr. Ashok Kumar, FASCRS
Call 05226664444Book AppointmentLAR is surgical removal of tumor-bearing rectum while preserving anal sphincter and bowel continuity. Standard procedure for mid and upper rectal cancers. Maintains normal bowel function in most patients. Requires complete mesorectal excision (TME) for optimal oncological outcomes.
Removes rectum with surrounding mesorectal tissue as oncological unit. Preserves autonomic nerves for sexual and urinary function. Creates anastomosis between proximal colon and distal rectum.
Laparoscopic approach preferred when feasible with equivalent oncological outcomes and better recovery.
Most patients achieve acceptable bowel function. Initially 4-6 bowel movements daily, improving to 2-3 over 3-6 months. 90% continence at 6-12 months post-op. Quality of life excellent in majority.
Local recurrence <5% with TME. Overall survival rates: Stage I 85-90%, Stage II 70-75%, Stage III 45-65%. Complications <5% with experienced surgeon.
Accurate estimate can be obtained from hospital while visiting the doctor.